论文部分内容阅读
LSA即脂质结合唾液酸(Lipid-bound Silica Acid)自BLIX首先从牛颌下腺分离出后国内外将其作为肿瘤标记物,相继报道且逐渐走向成熟,但LSA与TSA(Total Silica Acid)联合尤其与B超对比尚未见报道。本文将LSA、TSA与B超联合对肝癌患者进行联合、连续观察以探讨其对肝癌的临床价值。
LSA, Lipid-bound Silica Acid has been reported as a tumor marker at home and abroad since BLIX was first isolated from the submandibular gland, and has been reported successively and matured, but LSA and TSA (Total Silica Acid) are especially associated. No comparison with B ultrasound has been reported. This article will LSA, TSA and B ultrasound combined liver cancer patients in a joint, continuous observation to explore its clinical value of liver cancer.